Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-001927
Filing Date
2024-11-14
Accepted
2024-11-14 17:26:15
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084527_10q.htm   iXBRL 10-Q 709168
2 EXHIBIT 31.1 g084527_ex31-1.htm EX-31.1 10080
3 EXHIBIT 31.2 g084527_ex31-2.htm EX-31.2 10165
4 EXHIBIT 32.1 g084527_ex32-1.htm EX-32.1 4840
5 EXHIBIT 32.2 g084527_ex32-2.htm EX-32.2 4705
  Complete submission text file 0001753926-24-001927.txt   3721194

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20240930.xsd EX-101.SCH 36380
7 XBRL CALCULATION FILE lipo-20240930_cal.xml EX-101.CAL 42729
8 XBRL DEFINITION FILE lipo-20240930_def.xml EX-101.DEF 77958
9 XBRL LABEL FILE lipo-20240930_lab.xml EX-101.LAB 257983
10 XBRL PRESENTATION FILE lipo-20240930_pre.xml EX-101.PRE 190921
70 EXTRACTED XBRL INSTANCE DOCUMENT g084527_10q_htm.xml XML 484884
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 241464501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)